TTUHSC School of Pharmacy
HomeSOPImmunotherapeutics and Biotechnology

Immunotherapeutics and Biotechnology

DIB Banner

main image
left column image

Our mission is to develop innovative therapies for cancer and related conditions as well as educate the next generation of scientists and healthcare professionals. 

The vision of the Department of Immunotherapeutics and Biotechnology is to be a leader in precision oncology therapeutics through cutting-edge interdisciplinary research.


Texas Tech University HSC
Immunotherapeutics and Biotechnology
1718 Pine Street
Abilene, TX 79601-3044

Questions or more information on department or programs please email:


High Impact Publications

Dr. Sanjay K. Srivastava, Chair of Immunotherapeutics and Biotechnology and Associate Dean for Office of Sciences, and his team's recent publication, "Penfloridol: An Antipsychotic Agent Suppresses Metastatic Tumor Growth in Triple-Negative Breast Cancer by Inhibiting Integrin Signaling Axis."  Cancer Research, 76, 877-890, 2016. (Impact Factor  9.329) PMID: 26627008

Can also be found at:


Dr. Magdalena Karbowniczek, Professor in the Department of Immunotheapeutics and Biotechnology in Abilene, and her team’s recent publication, “Exosomes mediate the acquisition of the disease phenotypes by cells with normal genome in tuberous sclerosis complex." Dr. Karbowniczek’s laboratory studies the cellular and molecular mechanisms behind a rare disease tuberous sclerosis complex (TSC), which is caused by the inactivating mutations in tumor suppressor genes TSC1 and TSC2. The manuscript is scheduled for publication this year in the cancer journal Oncogene. (Impact Factor 8.459)... READ ARTICLE


right column image

Faculty Honors & Achievements

Dr. La-Beck

Dr. Irene La-Beck was invited to give a seminar at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences on September 28, 2017.


Dr. Wood

Dr. Laurence Wood was invited internally to speak at the TTUHSC School of Medicine in Lubbock on "The ISG15 Pathways in Immunity and Cancer."



Dr. SrivastavaDr. Sanjay Srivastava delivered a Plenary Talk and was the Session chair at First International Conference on Clinical Trials and Innovative Therapeutics in Cape Town, South Africa on July 2017. He is also invited as a plenary speaker at the CPCPT in Kayseri, Turkey on November 8, 2017.


Dr. Markiewski Dr. Maciej Markiewski was invited to speak at the 10th International Conference on Complement Therapeutics, Aegean Conference in Heraklion, Crete, Greece on June 2017. 

  Content updated: 10/17/17